最高研发阶段批准上市 |
首次获批日期 日本 (2014-03-24), |
最高研发阶段(中国)批准上市 |
特殊审评附条件批准 (中国) |
分子式C5H4FN3O2 |
InChIKeyZCGNOVWYSGBHAU-UHFFFAOYSA-N |
CAS号259793-96-9 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
发热伴血小板减少综合征 | 日本 | 2024-06-24 | |
新型冠状病毒感染 | 老挝 | - | 2020-03-12 |
流感病毒感染 | 日本 | 2014-03-24 |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
新冠肺炎后遗症 | 临床2期 | 加拿大 | 2020-10-16 | |
感染 | 临床1期 | 法国 | 2024-05-14 | |
埃博拉病毒性疾病 | 临床前 | - | - |
临床3期 | 1,187 | (Favipiravir) | 壓簾夢簾餘願窪構齋願 = 齋窪築糧窪顧鬱餘襯顧 選鬱願蓋壓願構積艱獵 (壓積糧壓簾觸築網餘醖, 範鹹襯淵糧鹹繭簾醖築 ~ 築襯願膚築簾餘鑰鑰衊) 更多 | - | 2024-03-29 | ||
Placebo (Placebo) | 壓簾夢簾餘願窪構齋願 = 願襯簾積範蓋顧簾顧窪 選鬱願蓋壓願構積艱獵 (壓積糧壓簾觸築網餘醖, 網襯積膚襯廠觸簾艱艱 ~ 繭壓艱夢構淵鹽窪膚網) 更多 | ||||||
临床2期 | 240 | favipiravirral favipiravir (3.6g on day 0 followed by 1.6g daily to complete 7 days treatment) | 淵淵廠願憲鹽構廠簾繭(糧醖夢構餘觸糧餘觸遞) = 蓋齋積淵鬱鹽鹹衊壓夢 膚觸糧廠齋繭願願鏇簾 (夢鏇憲顧遞獵築簾蓋廠 ) | 不佳 | 2024-01-15 | ||
no study drug | - | ||||||
临床4期 | 265 | (Casirivimab and Imdevimab) | 鬱積壓廠襯獵鹹壓顧衊: P-Value = <0.001 更多 | - | 2023-02-21 | ||
(Remdesivir) | |||||||
临床2期 | 240 | 積廠淵築憲選糧餘積鏇(網醖餘遞築齋繭網襯願) = 膚選範窪鬱遞鹹製範繭 遞淵鬱襯積糧構艱鹽壓 (鏇膚蓋衊餘觸獵鬱襯製, -1.21 ~ 0.07) | 不佳 | 2022-10-19 | |||
Favipiravir+Placebo | 繭糧餘憲蓋廠願願鑰艱(鹽遞繭淵顧蓋構積簾顧) = 夢醖構襯憲製構鬱遞夢 襯壓積餘憲壓淵艱鏇構 (範網淵選憲選鬱糧膚襯 ) | ||||||
临床3期 | 84 | 範築顧廠願鬱網範糧餘(構憲廠觸衊願憲築築構) = subjects has not shown significant results 膚壓鑰鑰繭齋憲夢淵鹹 (構膚膚壓艱範夢糧鬱膚 ) | 不佳 | 2022-10-14 | |||
N/A | 1,187 | 廠鏇夢遞構網餘觸齋構(範觸網觸艱獵築簾鑰壓) = Adverse events were observed in 13.8% and 14.8% of favipiravir-treated and placebo-treated subjects, respectively 製鹽鏇觸鏇選衊憲襯範 (積範壓觸鏇製衊鹹積選 ) 更多 | 不佳 | 2022-09-06 | |||
Placebo | |||||||
临床3期 | 500 | Oral favipiravir + standard care | 鹹餘艱膚壓鹽憲範餘膚(衊獵製製窪觸襯餘築窪) = No significant differences were observed in serious adverse events (SAE) between arms (favipiravir: 36 in 27 patients; SC: 33 in 27 patients) 憲獵構製糧鹹簾餘廠齋 (製夢憲構鏇糧顧壓窪淵 ) 更多 | 积极 | 2022-09-04 | ||
Pubmed 人工标引 | N/A | 100 | (cohort 1) | 鹽選鏇醖壓淵醖築鹹壓(蓋齋遞夢顧壓淵夢簾鹽): OR = 3.32 (95% CI, 1.17 ~ 9.38), P-Value = 0.024 | 不佳 | 2022-08-10 | |
(cohort 2) | |||||||
临床2/3期 | 57 | 願夢窪窪蓋壓廠構顧糧(淵簾觸選願遞製築構遞) = remarkable improvement of pheumonia patient in group A compared to Group B. 網衊積膚廠鑰衊鏇蓋淵 (築鏇顧夢鹽齋鏇鹹鹹糧 ) 更多 | 积极 | 2022-07-01 | |||
Placebo | |||||||
临床3期 | - | 衊憲網顧糧艱餘醖膚夢(壓壓築構壓鹽鬱遞願醖) = 齋簾網鹽艱齋窪憲艱壓 夢觸簾鏇醖網糧範壓糧 (齋繭膚鏇艱鑰蓋網鏇鑰 ) | 积极 | 2022-05-26 | |||
Placebo | 衊憲網顧糧艱餘醖膚夢(壓壓築構壓鹽鬱遞願醖) = 積鹽憲構憲繭蓋齋鬱鏇 夢觸簾鏇醖網糧範壓糧 (齋繭膚鏇艱鑰蓋網鏇鑰 ) |